-
Denufosol (INN) is an
inhaled drug for the
treatment of
cystic fibrosis,
being developed by
Inspire Pharmaceuticals and
sponsored by the
Cystic Fibrosis...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
- 5-OMe-UDP α,β-Me-ATP
Adenosine ADP ADPβS Ap3A AR-C 67085MX ATP ATPγS CTP dATP
Denufosol Diquafosol IDP ITP INS-365 INS-37217 MRS-2365 MRS-2690 MRS-2693 MRS-2768...
